BioPorto A/S
BIOPOR
Classement en actions
#22814
BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker... BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker tests, research tools, and antibodies to medical professionals and scientists worldwide, with operations across Europe, North America, and Asia. Among its offerings is the neutrophil gelatinase-associated lipocalin (NGAL) test, a precise quantitative particle-enhanced turbidimetric immunoassay designed for use on automated chemistry analyzers. The company further provides monoclonal antibodies essential for scientific, pharmaceutical, and clinical investigations. Additionally, BioPorto produces enzyme-linked immunosorbent assay (ELISA) kits and a versatile rapid assay device tailored for custom lateral flow assay development. Established in 1917, the company is headquartered in Hellerup, Denmark.
Prix de l'action
$0.16353606
Capitalisation boursière
$80.97M
Changement (1 jour)
-0.48%
Changement (1 an)
-43.22%
Pays
DK
Échange BioPorto A/S (BIOPOR)
Catégorie
Healthcare
Ratio P/B pour BioPorto A/S (BIOPOR)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de BioPorto A/S, le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour BioPorto A/S de 2026 à 2026
Ratio P/B à la fin de chaque année
| Année | Ratio P/B | Changez |
|---|---|---|
| Pas assez de données pour les dates fournies. | ||
Ratio P/B pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/B | Différence de Ratio P/B | Pays |
|---|---|---|---|
| 4.7411 | - |
US
|
|
| 3.0143 | - |
US
|
|
| 31.051 | - |
US
|
|
| - | - |
CN
|
|
| 6.6641 | - |
US
|
